Citation Impact

Citing Papers

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Seroprevalence of parvovirus B19 in the German population
2008
Parvovirus-B19-associated complications in renal transplant recipients
2007
The humoral immune response to influenza vaccination in lung transplant patients
2001
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis
2009 Standout
A Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Prime‐Boost Strategy for Pneumococcal Vaccination in Adult Liver Transplant Recipients
2008
Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer
2011
Influenza infection in patients before and after liver transplantation
2000
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Anti–Intercellular Adhesion Molecule-1 Antibodies in Sera of Heart Transplant Recipients: A Role in Endothelial Cell Activation
2005
Severe Sepsis and Septic Shock
2013 Standout
Immune reconstitution syndrome associated with opportunistic mycoses
2007
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review
2011
Cell-mediated immune response to influenza vaccination in lung transplant recipients
2004
Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients
2009
Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs
2009
Immune responsiveness in renal transplant recipients: Mycophenolic acid severely depresses humoral immunity in vivo
2002
Genetic predisposition to respiratory infection and sepsis
2011
Mycophenolate mofetil and its mechanisms of action
2000 Standout
Seroprevalence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management
2001
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Update on Myocarditis
2012 Standout
MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTION
2000
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
Outbreak of human parvovirus B19 in hospital workers
2000
Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving either Azathioprine or Mycophenolate: A Controlled Trial
2008
Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients
2008
Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial
2012
INFLUENZA VIRUS IMMUNIZATION EFFECTIVITY IN KIDNEY TRANSPLANT PATIENTS SUBJECTED TO TWO DIFFERENT TRIPLE-DRUG THERAPY IMMUNOSUPPRESSION PROTOCOLS
2000
Influenza vaccination in solid-organ transplant recipients
2012
Parvovirus B19
2004 Standout
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
2009
Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations
2011
Mycophenolate mofetil: therapeutic applications in kidney transplantation and immune-mediated renal disease
1999
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Human Parvovirus B19
2002 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Epidemiology of human parvovirus B19 in children with sickle cell disease
2003
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout

Works of J Leydon being referenced

Suppression of the humoral immune response by mycophenolate mofetil
1998
The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world
2000
Fifth disease in a small rural community. What are the consequences?
1999
Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease
2007
Rankless by CCL
2026